Deborah Fuller
14Patents
3h-index
29Co-inventors
60Inventor score
Filing activity: Apr 2, 1993 → Jul 1, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6200959A | Genetic induction of anti-viral immune response and genetic vaccine for filovirus | Chemistry; Metallurgy | 34 | Expired |
| US6558961B1 | Immunodiagnostics using particle delivery methods | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5470708A | Particle-mediated transformation of mammalian unattached cells | Chemistry; Metallurgy | 8 | Expired |
| US7699801B2 | Advanced genetic vaccines | Emerging Cross-Sectional Technologies | 3 | Active |
| US6881723B1 | Nucleic acid constructs | Human Necessities | 1 | Expired |
| US11389532B2 | Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS2, and/or s-HBsAg regions of the HBV envelope protein | Chemistry; Metallurgy | 1 | Active |
| US7223739B1 | Adjuvanted genetic vaccines | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11883488B2 | Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen | Chemistry; Metallurgy | 0 | Active |
| US11324819B2 | Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen | Chemistry; Metallurgy | 0 | Active |
| US11185583B2 | Multi-functional mucosal vaccine platform | Chemistry; Metallurgy | 0 | Active |
| US10766929B2 | De novo designed hemagglutinin binding proteins | Physics | 0 | Active |
| US9771395B2 | Enhanced influenza hemagglutinin binders | Physics | 0 | Active |
| US12285482B2 | Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS2, and/or S-HBsAg regions of the HBV envelope protein | Chemistry; Metallurgy | 0 | Active |
| US7022320B1 | Mycobacterium tuberculosis immunization | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.